A major concern with GLP-1RAs, despite their potent anti-obesity effects, is post-treatment weight rebound [16]
References Sisley S, Gutierrez-Aguilar R, Scott M, DAlessio DA, Sandoval DA, Seeley RJ
Similarly, the overall effect estimate for the composite kidney outcome was most likely driven by the effect of GLP-1 RA on severe albuminuria only and not on hard kidney endpoints
Acknowledgements The project including purchase of Victoza pens was supported by funding from The Danish Research Counsel, Health and Disease (reference number: 11-107683) and the University Investment Capital (UNIK): Food, Fitness and Pharma for Health and Disease from the Danish Ministry of Science, Technology and Innovation
doi: 10.1038/nm919 118 AbbasTFaivreEHolscherC